Recon: Novo Nordisk signs $1.1B deals with two biotechs for obesity drugs; Health Canada approves Pfizer’s hemophilia B gene therapy
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States